Source: Abstracts. Conference titles: World Congress of the Board of Pharmaceutical Sciences of FIP. Unidades: FCF, HU
Subjects: HIPERCOLESTEROLEMIA, EXPRESSÃO GÊNICA, FARMACOGENÉTICA
ABNT
ARAZI, Simone Sorkin et al. Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. 2007, Anais.. Amsterdam: International Pharmaceutical Federation, 2007. . Acesso em: 19 abr. 2024.APA
Arazi, S. S., Willrich, M. A. V., Dalla-Vecchia, F., Hirata, M. H., Dorea, E. L., Bernik, M. M. S., & Hirata, R. D. C. (2007). Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. In Abstracts. Amsterdam: International Pharmaceutical Federation.NLM
Arazi SS, Willrich MAV, Dalla-Vecchia F, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. Abstracts. 2007 ;[citado 2024 abr. 19 ]Vancouver
Arazi SS, Willrich MAV, Dalla-Vecchia F, Hirata MH, Dorea EL, Bernik MMS, Hirata RDC. Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients. Abstracts. 2007 ;[citado 2024 abr. 19 ]